| 영문 | iron deficiency anemia | 한글 | 철결핍빈혈 |
|---|---|---|---|
| 설명 | 적혈구의 기능은 산소를 운반하는데 있다. 적혈구 속에 산소와 결합을 하여 산소를 운반하는 혈색소라는 물질이 있다. 철은 이 혈색소의 중요한 부분을 이루는 것으로 철이 없으면 혈색소가 만들어질 수가 없다. 혈색소가 없으면 역시 적혈구도 만들어지지 않으므로 체내에 철이 부족하면 빈혈이 생긴다. 이 철결핍성 빈혈은 빈혈의 원인 중에서 가장 흔한 것이다(약 25%를 차지한다). 철저장량의 저하-결핍, 혈청철농도의 저하, 트란스페린량 상승, 트란스페린포화도의 저하, 혈색소농도 또는 헤마토크리트의 저하, 저색소성대적혈구를 특징으로 하는 빈혈로서, 생체 내에서 철이 장기에 걸쳐 결핍되며 그 때문에 혈색소 생산 감소에 의해 일어난다. 창자에서의 철흡수량 부족, 철의 수요 증대(유아기, 사춘기, 임신), 철소실과잉(출혈)에 의해 일어나며, 특히 사춘기에서 폐경기까지의 여성에게 많다. 증상으로서는 얼굴창백, 피로감, 피부창백, 손톱 변화(스푼 모양) 등을 나타낸다. 구강 영역에서는 혀의 접촉통, 발적, 건조감, 삼킴곤란을 수반하면 플러머-빈슨(Plummer-Vinson)증후군이라고 한다. 혈액 소견은 혈청철은 저하하며, 철결합능력의 상승, 저색소성 작은적혈구성을 나타낸다. |
||
| MD | Doctor of Medicine [Lat. Medicinae Doctor]; magnesium deficiency; main duct; maintenance dose; major... |
|---|---|
| GDH | glucose dehydrogenase; glutamate dehydrogenase; glycerophosphate dehydrogenase; glycol dehydrogenase... |
| ALDH | ALdehyde DeHydrogenase = ADH |
| ALDH | aldehyde dehydrogenase |
| LAD | lactic acid dehydrogenase; left anterior descending [artery]; left axis deviation; leukocyte adhesio... |
| FALDH | Fatty aldehyde dehydrogenase |
|---|---|
| ALDH | Aldehyde dehydrogenase |
| ALDH1 | Aldehyde dehydrogenase |
| AldDH | Aldehyde dehydrogenase |
| ALDH1 | Aldehyde dehydrogenase 1 |
| aldehyde dehydrogenase | <enzyme> An enzyme that oxidises an aldehyde in the presence of NAD+ and water to an acid and NADH. Before 1978, it was classified as EC 1.1.1.70. Chemical name: Aldehyde:NAD+ oxidoreductase Registry number: EC 1.2.1.3 (12 Dec 1998) |
|---|---|
| aldehyde dehydrogenase (acylating) | An oxidoreductase converting an aldehyde and CoA to acyl-CoA with NAD+ as H acceptor. (05 Mar 2000) |
| aldehyde dehydrogenase (NAD+) | An oxidoreductase reversibly converting aldehydes to acids with NADP+ as H acceptor. (05 Mar 2000) |
| aldehyde dehydrogenase (NAD(P)+) | An oxidoreductase reversibly converting aldehydes to acids with NAD+ or NADP+ as H acceptor. (05 Mar 2000) |
| betaine-aldehyde dehydrogenase | An oxidizing enzyme that catalyses the oxidation of betaine aldehyde with NAD+ and water to betaine and NADH; part of the choline oxidase system and of choline metabolism. (05 Mar 2000) |
| glucose-6-dehydrogenase deficiency | <biochemistry> An inherited condition that results in a deficiency in glucose-6-phosphate dehydrogenase. Particular drugs (sulphonamides) can exacerbate this problem. The result is haemolytic anaemia. (27 Sep 1997) |
| glucose-6-phosphate dehydrogenase deficiency | A deficiency of glucose-6-phosphate dehydrogenase, an enzyme important for maintaining cellular concentrations of reduced nucleotides. Deficiency of this enzyme is the commonest disease-causing enzyme defect in humans affecting an estimated 400 million people. The gene for this enzyme is on the X chromosome and there are various polymorphic forms. Males with the enzyme deficiency develop haemolytic anaemia when red blood cells are exposed to oxidant drugs such as the antimalarial primaquine, the sulfonamide antibiotics or sulfones, naphthalene moth balls, or fava beans. It can also cause anaemia of the newborn, and chronic nonspherocytic haemolytic anaemia. Inheritance: X-linked. (12 Sep 2002) |
| glucosephosphate dehydrogenase deficiency | A disease-producing enzyme deficiency subject to many variants, some of which cause a deficiency of enzyme activity in erythrocytes, leading to haemolytic anaemia. (12 Dec 1998) |
| pyruvate dehydrogenase complex deficiency | An autosomal recessive pyruvate metabolism disorder resulting from deficient enzyme activity in one of several proteins of pyruvate dehydrogenase complex, resulting in deficiency of acetyl CoA. Deficiency in acetyl CoA product reduces the synthesis of acetylcholine, thereby causing neurological abnormalities. Clinical presentations include lactic acidosis, mental retardation, and ataxia. (12 Dec 1998) |
| deficiency, glucose-6-phosphate dehydrogenase | Deficiency of G6PD is the commonest disease-causing enzyme defect in humans affecting an estimated 400 million people. The G6PD gene is on the X chromosome. Males with the enzyme deficiency develop anaemia due to breakup of their red blood cells when they are exposed to oxidant drugs such as the antimalarial primaquine, the sulfonamide antibiotics or sulfones, naphthalene moth balls, or fava beans. (12 Dec 1998) |
| acetic aldehyde | <chemical> A colourless, flammable liquid used in the manufacture of acetic acid, perfumes, and flavors. It is also an intermediate in the metabolism of alcohol. It has a general narcotic action and also causes irritation of mucous membranes. Large doses may cause death from respiratory paralysis. Chemical name: Acetaldehyde (12 Dec 1998) |
| active aldehyde | Any aldehyde derivative of thiamin pyrophosphate. (05 Mar 2000) |
| aflatoxin B1 aldehyde reductase | <enzyme> Catalyses the conversion of the dialdehydic form of aflatoxin b1-dihydrodiol to the dialcohol form Registry number: EC 1.1.1.- Synonym: aflatoxin b1-aldehyde reductase, afb1-ar (26 Jun 1999) |
| aldehyde | <chemistry> A carbon atom double-bonded to an oxygen, single-bonded to a hydrogen, and single-bonded to another chemical group (such as methane, benzene, another hydrogen, anything). The carbon oxygen double bond part is known as a carbonyl group (C=O). An example is acetaldehyde, which is a carbonyl group single-bonded to a hydrogen and single-bonded to a methane (a methyl group: CH3). (09 Oct 1997) |
| aldehyde base | An obsolete term for an imide. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|